In summary, the results of this study demonstrate that a decrease in PA production by lysosomal PLD1 inhibits autolysosome formation in the Pld1−/− liver, leading to hepatic steatosis, without affecting insulin sensitivity. The gene discussed is PLD1; the disease is fatty liver disease.